Recent Finacing
Recent Raise
Flindr Therapeutics develops precision oncology small-molecule drugs using its ImmunoGram Drug Discovery Engine to reverse-translate tumor and host heterogeneity into lab models for target identification and biomarker-guided patient selection.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
